XML 71 R15.htm IDEA: XBRL DOCUMENT v2.4.0.8
Share-Based Compensation (Notes)
12 Months Ended
Dec. 31, 2013
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Share-Based Compensation
 Share-Based Compensation
The Company's 2010 Incentive Compensation Plan (the “2010 Plan”) allows for the issuance of 2,500,000 shares of common stock. The 2010 Plan provides for the grant of stock options, restricted stock units, and other awards to its employees and directors.
The Company awards restricted stock units to certain key employees and non-employee directors. The restricted stock units vest ratably over a four year service period from the grant date. Restricted stock units are valued based on the market price on the date of the grant and are amortized on a straight-line basis over the vesting period. Compensation expense for restricted stock units is based on fair market value at the grant date.
The following table summarizes the nonvested restricted stock units as of December 31, 2013 and 2012:
 
 
Number of Restricted Stock Units
 
Weighted Average Grant Date Fair Value
 
Weighted Average Remaining Contractual
Term
(Years)
Nonvested as of December 31, 2011
 
75,922

 
$
14.02

 
3.2
Granted
 
87,414

 
18.02

 
 
Vested
 
(18,971
)
 
14.02

 
 
Forfeitures
 
(2,117
)
 
18.02

 
 
Nonvested as of December 31, 2012
 
142,248

 
$
16.42

 
2.8
Granted
 
202,523

 
24.19

 
 
Vested
 
(43,571
)
 
16.41

 
 
Forfeitures
 
(21,729
)
 
20.19

 
 
Nonvested as of December 31, 2013
 
279,471

 
$
21.76

 
2.8

Unrecognized stock compensation expense was $4.9 million and $1.8 million for the years ended December 31, 2013 and 2012, respectively.
The Company previously maintained a Key Employee Equity Plan (“Equity Plan”), a stock-based compensation plan that permitted the grant of stock options to Company employees and directors. Stock options under the Equity Plan were granted with an exercise price equal to or in excess of the fair value of the Company’s stock on the date of grant. Such options vest ratably over a two or four year service period and are exercisable ten years from the date of grant, but only to the extent vested as specified in each option agreement.
GTS previously maintained a Key Employee Equity Plan (“GTS Plan”), which permitted the grant of stock options to employees and directors. Stock options under the GTS Plan were granted with an exercise price equal to or in excess of the fair value of GTS’ stock on the date of grant. Such options vest ratably over a two or four year service period and are exercisable ten years from the date of grant, but only to the extent vested as specified in each option agreement. In connection with the Company’s merger with GTS effective upon the IPO, all options granted pursuant to the GTS Plan outstanding at the effective time of the merger became options to purchase shares of the Company’s common stock.
No options were granted by the Company in 2011, 2012 or 2013. Stock-based compensation expense was $1.5 million, $0.7 million, and $0.5 million for the years ended December 31, 2013, 2012 and 2011, respectively. The related estimated income tax benefit recognized in the accompanying consolidated statements of operations, net of estimated forfeitures, was $0.6 million, $0.3 million, and $0.2 million, respectively. 
A summary of the option activity under the equity plans for the years ended December 31, 2013 and 2012, respectively, is as follows: 
 
Shares
 
Weighted
Average
Exercise
Price
 
Weighted Average Remaining Contractual
Term
(Years)
 
Aggregate
Intrinsic
Value
 
 
 
 
 
 
 
(In thousands)
Outstanding as of December 31, 2011
1,811,536

 
$
11.41

 
4.8
 
$
4,927

Granted

 

 
 
 
 
Exercised
(226,068
)
 
9.59

 
 
 
 
Forfeited

 

 
 
 
 
Outstanding as of December 31, 2012
1,585,468

 
$
11.67

 
3.8
 
$
10,258

Granted

 

 
 
 
 
Exercised
(729,651
)
 
9.33

 
 
 
 
Forfeited

 

 
 
 
 
Outstanding as of December 31, 2013
855,817

 
$
13.67

 
3.0
 
$
11,365


There were 855,817, 1,563,725, and 1,684,140 options exercisable as of December 31, 2013, 2012 and 2011, respectively. As of December 31, 2013, for exercisable options, the weighted-average exercise price was $13.67, the weighted average remaining contractual term was 3.0 years, and the estimated aggregate intrinsic value was $13.28 per share. All granted options are non-qualified options. As of December 31, 2013, all options were vested.